0000899243-23-005547.txt : 20230217 0000899243-23-005547.hdr.sgml : 20230217 20230217192039 ACCESSION NUMBER: 0000899243-23-005547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Espinoza Octavio CENTRAL INDEX KEY: 0001905248 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 23644748 MAIL ADDRESS: STREET 1: C/O LIGAND PHARMACEUTICALS INC STREET 2: 3911 SORRENTO VALLEY BOULEVARD, STE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-15 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001905248 Espinoza Octavio 3911 SORRENTO VALLEY BOULEVARD, SUITE 110 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Common Stock 2023-02-15 4 F 0 849 72.98 D 18096 D Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units. /s/ Andrew Reardon, Attorney-in-Fact for Octavio Espinoza 2023-02-17